Sommaire

Numéro précédent | Numéro suivant

• • ·Table of Contents

    Page :A1

    
• • ·Editorial Board

    Page :A5

    
• • ·Information for Authors

    Page :A6

    
• • ·Information for Readers

    Page :A8

    

• Results of Expert Meetings

  • ·Preventing tomorrow's sudden cardiac death today : Dissemination of effective therapies for sudden cardiac death prevention

    Page :613-622

    Sana M. Al-Khatib, Gillian D. Sanders, Mark Carlson, Aida Cicic, Anne Curtis, Gregg C. Fonarow, Peter W. Groeneveld, David Hayes, Paul Heidenreich, Daniel Mark, Eric Peterson, Eric N. Prystowsky, Philip Sager, Marcel E. Salive, Kevin Thomas, Clyde W. Yancy, Wojciech Zareba, Douglas Zipes, for an expert panel participating in a Duke's Center for the Prevention of Sudden Cardiac Death Conference o

    Résumé Résumé Plan Plan

• Trial Design

  • ·Prevention of diabetes and cardiovascular disease in patients with impaired glucose tolerance: Rationale and design of the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial

    Page :623-632

    Robert M. Califf, Mitradev Boolell, Steven M. Haffner, M. Angelyn Bethel, John McMurray, Anil Duggal, Rury R. Holman, for the NAVIGATOR Study Group *

    Résumé Résumé Plan Plan  
  • ·Determining the most appropriate components for a composite clinical trial outcome

    Page :633-640

    M. Angelyn Bethel, Rury Holman, Steven M. Haffner, Robert M. Califf, Alice Huntsman-Labed, Tsushung A. Hua, John McMurray

    Résumé Résumé Plan Plan  
  • ·A randomized controlled trial to evaluate the safety and efficacy of cardiac contractility modulation in patients with systolic heart failure: Rationale, design, and baseline patient characteristics

    Page :641

    William T. Abraham, Daniel Burkhoff, Koonlawee Nademanee, Peter Carson, Robert Bourge, Kenneth A. Ellenbogen, Michael Parides, Alan Kadish, On behalf of the FIX-HF-5 Investigators and Coordinators i

    Résumé Résumé Plan Plan  
  • ·Design and methodology of the NorthStar study: NT-proBNP stratified follow-up in outpatient heart failure clinics — A randomized Danish multicenter study

    Page :649-655

    Morten Schou, Finn Gustafsson, Lars Videbaek, John Markenvard, Hans Ulriksen, Henrik Ryde, Jens C.H. Jensen, Tonny Nielsen, Anne S. Knudsen, Christian D. Tuxen, Jens Handberg, Per J. Sørensen, Geert Espersen, Søren Lind-Rasmussen, Niels Keller, Kenneth Egstrup, Olav W. Nielsen, Jawdat Abdulla, Ole Nyvad, Jens Toft, Per R. Hildebrandt

    Résumé Résumé Plan Plan  

• Clinical Investigations

  • ·Efficacy of LOw-dose DObutamine Stress-Echocardiography to predict Cardiac Resynchronization Therapy Response (LODO-CRT) multicenter prospective study—Design and rationale

    Page :656-661

    Carmine Muto, Maurizio Gasparini, Saverio Iacopino, Carlo Peraldo, Antonio Curnis, Biagio Sassone, Paolo Diotallevi, Mario Davinelli, Sergio Valsecchi, Bernardino Tuccillo

    Résumé Résumé Plan Plan  
  • ·Predictors of mortality after discharge in patients hospitalized with heart failure: An analysis from the Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)

    Page :662-673

    Christopher M. O'Connor, William T. Abraham, Nancy M. Albert, Robert Clare, Wendy Gattis Stough, Mihai Gheorghiade, Barry H. Greenberg, Clyde W. Yancy, James B. Young, Gregg C. Fonarow

    Résumé Résumé Plan Plan  
  • ·Quality of care and outcomes among patients with heart failure and chronic kidney disease: A Get With the Guidelines—Heart Failure Program study

    Page :674-681

    Uptal D. Patel, Adrian F. Hernandez, Li Liang, Eric D. Peterson, Kenneth A. LaBresh, Clyde W. Yancy, Nancy M. Albert, Gray Ellrodt, Gregg C. Fonarow

    Résumé Résumé Plan Plan  
  • ·The economic returns of pediatric clinical trials of antihypertensive drugs

    Page :682-688

    Carissa M. Baker-Smith, Daniel K. Benjamin, Henry G. Grabowski, Elizabeth D. Reid, Barry Mangum, John V. Goldsmith, M. Dianne Murphy, Rex Edwards, Eric L. Eisenstein, Jessica Sun, Robert M. Califf, Jennifer S. Li

    Résumé Résumé Plan Plan  
  • ·Effects of disclosing financial interests on participation in medical research: A randomized vignette trial

    Page :689-697

    Kevin P. Weinfurt, Mark A. Hall, Joëlle Y. Friedman, N. Chantelle Hardy, Alice K. Fortune-Greeley, Janice S. Lawlor, Jennifer S. Allsbrook, Li Lin, Kevin A. Schulman, Jeremy Sugarman

    Résumé Résumé Plan Plan  
  • ·Long-term economic outcomes associated with intensive versus moderate lipid-lowering therapy in coronary artery disease: Results from the Treating to New Targets (TNT) Trial

    Page :698-705

    Daniel B. Mark, J. David Knight, Patricia A. Cowper, Linda Davidson-Ray, Kevin J. Anstrom

    Résumé Résumé Plan Plan  
  • ·Treatment of isolated secundum atrial septal defects: Impact of age and defect morphology in 1,013 consecutive patients

    Page :706-712

    Gianfranco Butera, Enrico Romagnoli, Mario Carminati, Massimo Chessa, Luciane Piazza, Diana Negura, Alessandro Giamberti, Raul Abella, Giuseppe Pomè, Claudia Condoluci, Alessandro Frigiola

    Résumé Résumé Plan Plan  
  • ·C-Reactive protein predicts severity, progression, and prognosis of asymptomatic aortic valve stenosis

    Page :713-718

    Koichiro Imai, Hiroyuki Okura, Teruyoshi Kume, Ryotaro Yamada, Yoshinori Miyamoto, Takahiro Kawamoto, Nozomi Watanabe, Yoji Neishi, Eiji Toyota, Kiyoshi Yoshida

    Résumé Résumé Plan Plan  
  • ·Nine-year trends in achievement of risk factor goals in the US and European outpatients with cardiovascular disease

    Page :719-727

    Benjamin A. Steinberg, Deepak L. Bhatt, Shamir Mehta, Philip A. Poole-Wilson, Philip O'Hagan, Gilles Montalescot, Christie M. Ballantyne, Christopher P. Cannon

    Résumé Résumé Plan Plan  
  • ·Clinical characteristics associated with poor long-term survival among patients with diabetes mellitus undergoing saphenous vein graft interventions

    Page :728-735

    Rajendra H. Mehta, Emily Honeycutt, Linda K. Shaw, Michael H. Sketch

    Résumé Résumé Plan Plan  
  • ·The prognostic importance of abnormal heart rate recovery and chronotropic response among exercise treadmill test patients

    Page :736-744

    Thomas M. Maddox, Colleen Ross, P. Michael Ho, Frederick A. Masoudi, David Magid, Stacie L. Daugherty, Pam Peterson, John S. Rumsfeld

    Résumé Résumé Plan Plan  
  • ·Sirolimus-eluting and paclitaxel-eluting stents for the treatment of coronary bifurcations

    Page :745-750

    Azeem Latib, John Cosgrave, Cosmo Godino, Asif Qasim, Simon J. Corbett, Davide Tavano, Nuccia Morici, Nicole Cristell, Alaide Chieffo, Mauro Carlino, Matteo Montorfano, Flavio Airoldi, Antonio Colombo

    Résumé Résumé Plan Plan
  • ·Systemic exposure of everolimus after stent implantation: A pharmacokinetic study

    Page :751.e1

    Marcus Wiemer, Ashok Seth, Praveen Chandra, Jörg Neuzner, Gert Richardt, Jan J. Piek, Martin Desaga, Carlos Macaya, Cornelis J. Bol, Karine Miquel-Hebert, Karolien De Roeck, Patrick W. Serruys

    Résumé Résumé Plan Plan  
  • ·Angiotensin-converting enzyme 2 A1075G polymorphism is associated with survival in an acute coronary syndromes cohort

    Page :752-758

    Barry R. Palmer, Martin D. Jarvis, Anna P. Pilbrow, Katrina L. Ellis, Chris. M. Frampton, Lorraine Skelton, Tim G. Yandle, Rob N. Doughty, Gillian A. Whalley, Chris J. Ellis, Richard W. Troughton, A. Mark Richards, Vicky A. Cameron

    Résumé Résumé Plan Plan  
  • ·Decreased heart rate variability is associated with higher levels of inflammation in middle-aged men

    Page :759.e1

    Rachel Lampert, J. Douglas Bremner, Shaoyong Su, Andrew Miller, Forrester Lee, Faiz Cheema, Jack Goldberg, Viola Vaccarino

    Résumé Résumé Plan Plan  
  • ·Albumin excretion in acute myocardial infarction: A guide for long-term prognosis

    Page :760-768

    Giuseppe Berton, Rocco Cordiano, Stefano Mazzuco, Ethan Katz, Renzo De Toni, Paolo Palatini

    Résumé Résumé Plan Plan  
  • ·Bleeding and outcome in acute coronary syndrome: Insights from continuous electrocardiogram monitoring in the Integrilin and Enoxaparin Randomized Assessment of Acute Coronary Syndrome Treatment (INTERACT) trial

    Page :769-775

    Andrew T. Yan, Raymond T. Yan, Thao Huynh, Paul DeYoung, Andrew Weeks, David H. Fitchett, Anatoly Langer, Shaun G. Goodman, for the INTERACT Investigators

    Résumé Résumé Plan Plan  
  • ·Nephrotoxicity of iodixanol versus ioversol in patients with chronic kidney disease: The Visipaque Angiography/Interventions with Laboratory Outcomes in Renal Insufficiency (VALOR) Trial

    Page :776-782

    Michael R. Rudnick, Charles Davidson, Warren Laskey, J. Lawrence Stafford, Paul F. Sherwin, For the VALOR Trial Investigators f

    Résumé Résumé Plan Plan  
  • ·Long-term mortality with multiple treadmill exercise test abnormalities: Comparison between patients with and without cardiovascular disease

    Page :783-789

    Bilal Aijaz, Luciano Babuin, Ray W. Squires, Stephen L. Kopecky, Bruce D. Johnson, Randal J. Thomas, Thomas G. Allison

    Résumé Résumé Plan Plan  
  • ·Effects of exogenous metabolic substrate modulation on exercise-induced myocardial ischemia

    Page :790-796

    Peter Bogaty, Paul Poirier, Luce Boyer, Serge Simard, Johanne Morin, Gilles R. Dagenais

    Résumé Résumé Plan Plan  
  • ·Clinical implications of a next-day follow-up electrocardiogram in patients with non-ST elevation acute coronary syndromes

    Page :797-803

    Salem Alkaabi, Fahad Baslaib, Amparo Casanova, Andrew T. Yan, David Fitchett, Aurora Mendelsohn, Jano Y. Nikhil, Anatoly Langer, Shaun G. Goodman, on behalf of the Canadian Acute Coronary Syndrome Registry Investigators c

    Résumé Résumé Plan Plan  

• Letters to the Editor

  • ·Transient ST-segment elevation myocardial infarction

    Page :e39

    Oscar M.P. Jolobe

    
  • ·Letter to the Editor

    Page :e41

    Radhakrishnan Ramaraj

    
  • ·Letter to the Editor

    Page :e43

    Alan Keith Berger

    
  • ·Letter to the Editor

    Page :e45

    Simcha R. Meisel, Avraham Shotan